New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Q32 Bio Inc. (QTTB) vs Scribe Therapeutics Inc. (SCTX)
- Q32 Bio Inc. QTTB 8.34 −1.65%
- Scribe Therapeutics Inc. SCTX 12.07 −8.70%
Q32 Bio Inc. and Scribe Therapeutics Inc. are both Biotechnology companies. Q32 Bio Inc. and Scribe Therapeutics Inc. are of similar size ($253.8M and $250.4M). Scribe Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Across the 4 metrics below, Q32 Bio Inc. leads on 3 and Scribe Therapeutics Inc. on 1.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack